Mitarbeiter: 02 (2023.0)Rechtsform: 5485Größe: PMEGründungsdatum: 2023-03-13 (3 Jahre)Status: AktivBranche: Commerce de détail de produits pharmaceutiques en magasin spécialiséStandort: FONTAINE-LE-COMTE (86240), Vienne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ARANDEL : revenue, balance sheet and financial ratios
PHARMACIE ARANDEL is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FONTAINE-LE-COMTE (86240),
this company of category PME
shows in 2025 a net income positive of 11 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2025, PHARMACIE ARANDEL generates positive net income of 11 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 34 k€ -> 11 k€.
Nettoergebnis (2025)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 440%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Verschuldungsgrad (2025)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
439.939%
Finanzielle Autonomie (2025)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen PHARMACIE ARANDEL
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2024
2025
Verschuldungsgrad
512.855
439.939
Finanzielle Autonomie
11.387
13.255
Rückzahlungsfähigkeit
None
None
Cashflow / Umsatz
None%
None%
Positionnement sectoriel
Debt ratio
439.942025
2024
2025
Q1: 13.71
Méd: 49.76
Q3: 129.07
Watch
In 2025, the debt ratio of PHARMACIE ARANDEL (439.94) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
13.26%2025
2024
2025
Q1: 33.42%
Méd: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE ARANDEL (13.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 62.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2025)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
62.82
Entwicklung der Liquiditätskennzahlen PHARMACIE ARANDEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2024
2025
Liquiditätsquote
71.429
62.82
Zinsdeckung
None
None
Positionnement sectoriel
Liquidity ratio
62.822025
2024
2025
Q1: 131.03
Méd: 182.29
Q3: 258.7
Watch
In 2025, the liquidity ratio of PHARMACIE ARANDEL (62.82) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positionnement de PHARMACIE ARANDEL dans son secteur
Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé
Bewertungsschätzung
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ARANDEL is estimated at
172 321 €
(range 116 938€ - 270 396€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
116k€172k€270k€
172 321 €Range: 116 938€ - 270 396€
NAF 5 année 2025
Valuation method used
Net Income Multiple
10 848 €
×
15.9x
=172 322 €
Range: 116 938€ - 270 397€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ARANDEL with other companies in the same sector:
Frequently asked questions about PHARMACIE ARANDEL
What is the revenue of PHARMACIE ARANDEL ?
The revenue of PHARMACIE ARANDEL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE ARANDEL profitable?
Yes, PHARMACIE ARANDEL generated a net profit of 11 k€ in 2025.
Where is the headquarters of PHARMACIE ARANDEL ?
The headquarters of PHARMACIE ARANDEL is located in FONTAINE-LE-COMTE (86240), in the department Vienne.
Where to find the tax return of PHARMACIE ARANDEL ?
The tax return of PHARMACIE ARANDEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ARANDEL operate?
PHARMACIE ARANDEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen